A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Deucravacitinib in Participants with Active Psoriatic Arthritis who are Naïve to Biologic Disease-modifying Anti rheumatic Drugs

  • Antony, Anna (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusActive
Effective start/end date3/05/22 → 2/05/27

Keywords

  • phase 3 study
  • treatment efficacy
  • treatment safety
  • psoriatic arthritis
  • randomised control trial